Search Results - "Rødevand, Erik"

Effectiveness and Persistence in SB4‐ and Reference Etanercept–Treated Rheumatoid Arthritis Patients in Ordinary Clinical Practice in Norway by Haugeberg, Glenn, Bakland, Gunnstein, Rødevand, Erik, Hansen, Inger Johanne Widding, Diamantopoulos, Andreas, Pripp, Are Hugo

“…Objective Biosimilars represent cost‐effective alternatives to reference biologic disease‐modifying antirheumatic drugs. Our objective was to compare drug…”
Get full text

Switching between TNF inhibitors in psoriatic arthritis: data from the NOR-DMARD study by Fagerli, Karen Minde, Lie, Elisabeth, van der Heijde, Désirée, Heiberg, Marte Schrumpf, Kalstad, Synøve, Rødevand, Erik, Mikkelsen, Knut, Lexberg, Ase Stavland, Kvien, Tore K

“…Tumour necrosis factor inhibitors (TNFi) are efficacious in patients with psoriatic arthritis (PsA), but some patients do not respond or do not tolerate their…”
Get more information

Four-year follow-up of inflammatory arthropathy patients treated with golimumab: Data from the observational multicentre NOR-DMARD study by Michelsen, Brigitte, Sexton, Joseph, Wierød, Ada, Bakland, Gunnstein, Rødevand, Erik, Krøll, Frode, Kvien, Tore K.

“…To compare (1) golimumab drug survival and efficacy in bDMARD naïve compared with non-naïve rheumatoid arthritis (RA), psoriatic arthritis (PsA) and axial…”
Get full text

Norwegian society of rheumatology recommendations on diagnosis and treatment of patients with giant cell arteritis by Haaversen, Anne Bull, Brekke, Lene Kristin, Bakland, Gunnstein, Rødevand, Erik, Myklebust, Geirmund, Diamantopoulos, Andreas P

“…To provide clinical guidance to Norwegian Rheumatologists and other clinicians involved in diagnosing and treating patients with giant cell arteritis (GCA)…”
Get full text

Patient satisfaction with nursing consultations in a rheumatology outpatient clinic: a 21-month randomised controlled trial in patients with inflammatory arthritides by Koksvik, Hege Svean, Hagen, Kåre Birger, Rødevand, Erik, Mowinckel, Petter, Kvien, Tore K, Zangi, Heidi A

“…To study the effect of individual nursing consultations in patients treated with disease-modifying antirheumatic drugs (DMARDs) in a rheumatology outpatient…”
Get more information

Discordance between tender and swollen joint count as well as patient's and evaluator's global assessment may reduce likelihood of remission in patients with rheumatoid arthritis and psoriatic arthritis: data from the prospective multicentre NOR-DMARD study by Michelsen, Brigitte, Kristianslund, Eirik Klami, Hammer, Hilde Berner, Fagerli, Karen Minde, Lie, Elisabeth, Wierød, Ada, Kalstad, Synøve, Rødevand, Erik, Krøll, Frode, Haugeberg, Glenn, Kvien, Tore K

“…To investigate the predictive value of discordance between (1) tender and swollen joint count and (2) patient's and evaluator's global assessment on remission…”
Get more information

Treat to target strategy in early rheumatoid arthritis versus routine care – A comparative clinical practice study by Brinkmann, Gina Hetland, Norvang, Vibeke, Norli, Ellen Sauar, Grøvle, Lars, Haugen, Anne Julsrud, Lexberg, Åse Stavland, Rødevand, Erik, Bakland, Gunnstein, Nygaard, Halvor, Krøll, Frode, Widding-Hansen, Inger Johanne, Bjørneboe, Olav, Thunem, Cathrine, Kvien, Tore, Mjaavatten, Maria Dahl, Lie, Elisabeth

“…To assess the 2-year effect on disease activity and health-related quality of life (HRQoL) of implementing a clinical practice treat-to-target (T2T) strategy…”
Get full text

Achievement of Remission and Low Disease Activity Definitions in Patients with Rheumatoid Arthritis in Clinical Practice: Results from the NOR-DMARD Study by Uhlig, Till, Lie, Elisabeth, Norvang, Vibeke, Lexberg, Åse Stavland, Rødevand, Erik, Krøll, Frode, Kalstad, Synøve, Olsen, Inge C, Kvien, Tore K

“…To examine the frequency of 6 definitions for remission and 4 definitions for low disease activity (LDA) after starting a disease-modifying antirheumatic drug…”
Get full text

Does Older Age have an Impact on Rituximab Efficacy and Safety? Results from the NOR-DMARD Register by Mielnik, Pawel, Sexton, Joseph, Lie, Elisabeth, Bakland, Gunnstein, Loli, Liz P., Kristianslund, Eirik K., Rødevand, Erik, Lexberg, Åse S., Kvien, Tore K.

“…Objective The objective of this study was to compare the efficacy and safety of rituximab in older vs younger patients with rheumatoid arthritis. Methods Data…”
Get full text

Effectiveness and retention rates of methotrexate in psoriatic arthritis in comparison with methotrexate-treated patients with rheumatoid arthritis by Lie, Elisabeth, van der Heijde, Désirée, Uhlig, Till, Heiberg, Marte S, Koldingsnes, Wenche, Rødevand, Erik, Kaufmann, Cecilie, Mikkelsen, Knut, Kvien, Tore K

“…To examine the effectiveness and 2-year retention rates of methotrexate (MTX) in MTX naïve patients with psoriatic arthritis (PsA). Data on 430 patients with…”
Get more information

First-time prescriptions of biological disease-modifying antirheumatic drugs in rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis 2002-2011: data from the NOR-DMARD register by Lie, Elisabeth, Fagerli, Karen M, Mikkelsen, Knut, Rødevand, Erik, Lexberg, Ase, Kalstad, Synøve, Uhlig, Till, Kvien, Tore K

Get more information

The comparative one‐year performance of anti–tumor necrosis factor α drugs in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: Results from a longitudinal, observational, multicenter study by Heiberg, Marte Schrumpf, Koldingsnes, Wenche, Mikkelsen, Knut, Rødevand, Erik, Kaufmann, Cecilie, Mowinckel, Petter, Kvien, Tore K.

“…Objective To compare the 1‐year retention rates of anti–tumor necrosis factor α (anti‐TNFα) medications in patients with rheumatoid arthritis (RA), psoriatic…”
Get full text

Paid work is associated with improved health-related quality of life in patients with rheumatoid arthritis by Grønning, Kjersti, Rødevand, Erik, Steinsbekk, Aslak

“…Numerous patients with rheumatoid arthritis (RA) end their working career due to consequences of the disease. No publication has reported whether there is an…”
Get full text

Value of MRI and ultrasound for prediction of therapeutic response and erosive progression in patients with early rheumatoid arthritis managed by an aggressive treat-to-target strategy by Sundin, Ulf, Sundlisater, Nina Paulshus, Aga, Anna-Birgitte, Sexton, Joseph, Nordberg, Lena Bugge, Hammer, Hilde Berner, van der Heijde, Desirée, Kvien, Tore K, Haavardsholm, Espen A, Lillegraven, Siri, Fremstad, Hallvard, Madland, Tor Magne, Lexberg, Åse Stavland, Haukeland, Hilde, Rødevand, Erik, Høili, Christian, Stray, Hilde, Bendvold, Anne Noraas, Hansen, Inger W, Bakland, Gunnstein

“…ObjectivesTo investigate if inflammation detected by MRI or ultrasound at rheumatoid arthritis (RA) onset is predictive of erosive progression or poor response…”
Get full text

Treatment strategies in patients with rheumatoid arthritis for whom methotrexate monotherapy has failed: data from the NOR-DMARD register by Lie, Elisabeth, van der Heijde, Désirée, Uhlig, Till, Mikkelsen, Knut, Kalstad, Synøve, Kaufmann, Cecilie, Rødevand, Erik, Kvien, Tore K

“…To compare the effectiveness of adding synthetic disease-modifying antirheumatic drugs (sDMARDs) versus tumour necrosis factor α inhibitors (TNFi) to…”
Get more information

Effectiveness of sulfasalazine and methotrexate in 1102 DMARD-naïve patients with early RA by LIE, Elisabeth, UHLIG, Till, DER HEIJDE, Désirée Van, RØDEVAND, Erik, KALSTAD, Synøve, KAUFMANN, Cecilie, MIKKELSEN, Knut, KVIEN, Tore K

“…To compare baseline characteristics, responses and drug survival in patients with early RA starting SSZ or MTX in a real-life setting. The analyses included…”
Get full text

Predicting achievement of the treatment targets at 6 months from 3-month response levels in rheumatoid arthritis: data from real-life follow-up in the NOR-DMARD study by Norvang, Vibeke, Sexton, Joseph, Kristianslund, Eirik K, Olsen, Inge C, Uhlig, Till, Bakland, Gunnstein, Krøll, Frode, Rødevand, Erik, Wierød, Ada, Kvien, Tore K, Smolen, Josef S, Aletaha, Daniel, Haavardsholm, Espen A

“…ObjectiveWhen initiating a new therapy in patients with rheumatoid arthritis (RA), current treatment recommendations suggest escalating therapy in case of poor…”
Get full text

Time trends in disease activity, response and remission rates in rheumatoid arthritis during the past decade: results from the NOR-DMARD study 2000-2010 by Aga, Anna-Birgitte, Lie, Elisabeth, Uhlig, Till, Olsen, Inge Christoffer, Wierød, Ada, Kalstad, Synøve, Rødevand, Erik, Mikkelsen, Knut, Kvien, Tore K, Haavardsholm, Espen A

“…To investigate whether baseline disease activity levels and responses in patients with rheumatoid arthritis (RA) changed during the period 2000-2010. Data were…”
Get more information

Drug Insight: anti-tumor necrosis factor therapy for inflammatory arthropathies during reproduction, pregnancy and lactation by Skomsvoll, Johan F, Wallenius, Marianne, Koksvik, Hege S, Rødevand, Erik, Salvesen, Kjell Å, Spigset, Olav, Kvien, Tore K

“…Tumor necrosis factor (TNF) antagonists are widely used to reduce disease activity and joint damage, and to improve health-related quality of life in patients…”
Get full text

Ultrasound in management of rheumatoid arthritis: ARCTIC randomised controlled strategy trial by Haavardsholm, Espen A, Aga, Anna-Birgitte, Olsen, Inge Christoffer, Lillegraven, Siri, Hammer, Hilde B, Uhlig, Till, Fremstad, Hallvard, Madland, Tor Magne, Lexberg, Åse Stavland, Haukeland, Hilde, Rødevand, Erik, Høili, Christian, Stray, Hilde, Noraas, Anne, Hansen, Inger Johanne Widding, Bakland, Gunnstein, Nordberg, Lena Bugge, van der Heijde, Désirée, Kvien, Tore K

“…Objective To determine whether a treatment strategy based on structured ultrasound assessment would lead to improved outcomes in rheumatoid arthritis, compared…”
Get full text